本篇曼彻斯特论文代写-替代方案的选择讲了罗氏产品私人有限公司是澳大利亚一家拥有多项专利药物的大型制药公司。该公司感到压力，因为大量的专利将在未来三年到期。为了解决这个问题，公司决定扩大生产线。作为产品经理，我想到了两种不同的替代方案，即推出药物LDE225或BKM120。本篇曼彻斯特论文代写文章由英国第一论文 Assignment First辅导网整理，供大家参考阅读。
Roche Product Private Limited is a large pharmaceutical company in Australia with a number of patent drugs. The firm is feeling pressure as huge amount of patent is expiring in upcoming next three years. It has decided to expand its production line to cope with the issue. Being the product manager has came up with idea of two different alternatives namely launching of drug LDE225 or BKM120.
Recommendation on new Investment has been made in coming paragraph on the drugs manufacturing to be opted within the company’s research department. The development of first drug LDE225 will help in slowing down the cancer growth while the second drug will block a certain type of protein which will be crucial for cancer cell development.
Analysis of the options selected
Drug LDE225, has following initial outlay cost in accordance with the project leader only if the project being launched –
Development costs: 20 million
Testing costs: 10 million
Initial Marketing costs: 12 million
Initial outlay: 42 million
Sales have been expected to be $36 million and it is expected to grow at a pace of 12% for the first three year and will stay in line with inflation in next 10 years.
Drug BKM120 will start generating sales from next year with following cost and revenue analysis:
Sales revenue $17.4 (7% increase in next 10 year)
Marketing cost $10 million